Dianthus Therapeutics DNTH
NASDAQ DNTH
$88.05 +0.89 (+1.02%)
At close: Sep 30, 2026 · 4:00 PM EDT

Dianthus Therapeutics (DNTH) Other Operating Expenses (2023 - 2024)

Updated

Dianthus Therapeutics' Other Operating Expenses came in at -$4.8 million for Q4 2024.

Analysis

Dianthus Therapeutics (DNTH) Other Operating Expenses (2023 - 2024) Analysis & Trends

  • The Q4 2024 figure represents the highest quarterly Other Operating Expenses since Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Dianthus Therapeutics 3.74 Bn 3.68 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -4.80 Mn
Jun 30, 2023 -1.92 Mn
Mar 31, 2023 -18.00 Mn
API Access

Dianthus Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=DNTH&period=max&api_key=YOUR_API_KEY